World Investment Advisors Has $2 Million Stake in iShares Biotechnology ETF $IBB

World Investment Advisors boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 50.4% in the 4th quarter, HoldingsChannel.com reports. The fund owned 11,853 shares of the financial services provider’s stock after purchasing an additional 3,973 shares during the quarter. World Investment Advisors’ holdings in iShares Biotechnology ETF were worth $2,001,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the second quarter worth $25,000. Basepoint Wealth LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $26,000. Cary Street Partners Financial LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $29,000. Copia Wealth Management acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $34,000. Finally, Caitlin John LLC bought a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth $34,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB opened at $173.64 on Friday. The stock has a 50 day moving average price of $170.61 and a 200 day moving average price of $170.66. iShares Biotechnology ETF has a 52 week low of $123.61 and a 52 week high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were issued a dividend of $0.0238 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.1%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.